RESEARCH TRIANGLE PARK, N.C.–Cell Microsystems, a provider of innovative tools for single cell research, announced today it has received two NIH Small Business Innovation and Research awards totaling $1.9M to automate CRISPR workflows using its proprietary CellRaft Technology. Nick Trotta, PhD, Director of Genomics Programs, described the awards saying, “These grants will accelerate our on-going […]
By reason of chairman Klas Cramborn’s death, the Board of Directors of Phase Holographic Imaging (PHI) has decided to appoint Mats Lundwall as acting chairman of the Board. “Klas has meant a lot to PHI’s development. With his strategic skills in combination integrity and humor Klas has led the Board in a very commendable way […]
LONGMONT, Colo. — KromaTiD, Inc. announced today that after successfully meeting the Phase 1 grant milestones, the company has been awarded Phase 2 funding from a Fast Track Small Business Innovation Research (SBIR) grant from the National Human Genome Research Institute. The SBIR program enables scientific excellence and technological innovation by incentivizing small businesses to […]
Phasefocus, the Sheffield-based company supplying tools to help researchers develop cures for cancer and stem cell therapies, has secured additional investment as it prepares to launch the newest version of its flagship live cell imaging and analysis system, Livecyte™. Livecyte enables research biologists to automatically quantify and compare dynamic live cell behaviour in an easy-to-use […]
Partnerships with eight non-profit organizations to strengthen CST’s relationship with local community DANVERS, MA – Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, today announced that they have formalized partnerships with eight local non-profit organizations. These partnerships will strengthen CST’s alignment with organizations that encourage science and environmental education, arts, and […]
– Increased flexibility allows researchers to select CD3+ cells from a sample of whole human peripheral blood – RANCHO CORDOVA, Calif. — ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing, today announced the release of the enhanced X-MINI® CD3 Selection Kit for the research market. The new X-MINI®CD3 Selection […]
WATERTOWN, Mass.– 1CellBio, Inc., today announced a new program to supply select customers with its proprietary inDrop™ hydrogel beads synthesized with custom primers that target user-specified transcripts. “This new program enables researchers to focus their sequencing depth on their genes of interest rather than the full transcriptome,” said Colin J.H. Brenan, PhD, Chief Executive Officer at […]
The new xCELLigence RTCA ePacer provides a solution that uses electrical pacing to functionally mature cardiomyocytes. SAN DIEGO–On March 11, 2019, ACEA Biosciences – A Part of Agilent unveiled the new xCELLigence® RTCA ePacerTM during their workshop held at the Society of Toxicology (SOT) Annual Meeting in Baltimore. Human induced pluripotent stem cell cardiomyocytes (hiPSC-CM) are […]
Peak Serum, Inc. has entered into a strategic partnership with Japanese biotechnology product distributor, Vita, Inc. Vita, a distributor and marketer of biotechnology products, represents trusted suppliers from various countries and prides itself on reducing the risk of purchasing raw materials for use in research and manufacturing. “Vita is trusted by life science companies around the […]
AMSBIO announces XerumFree™ – a new concept in cell culture that allows you to culture cells without the use of serum. XerumFree™ has been developed taking into account what is missing in traditional basal cell culture media to sustain growth of all cell types, which is a nutritional approach at the cellular level. Containing no animal or human […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
